RRA
GILD icon

Round Rock Advisors’s Gilead Sciences GILD Stock Holding History

Round Rock Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,023
Closed -$335K – 345
2025
Q2 		$335K Sell
3,023
-30
-1% -$3.19K 0.06% 169
2025
Q1 		$342K Buy
3,053
+50
+2% +$5.16K 0.06% 160
2024
Q4 		$277K Buy
3,003
+53
+2% +$4.77K 0.06% 171
2024
Q3 		$247K Hold
2,950
– – 0.06% 158
2024
Q2 		$202K Hold
2,950
– – 0.05% 173
2024
Q1 		$216K Hold
2,950
– – 0.05% 180
2023
Q4 		$239K Buy
+2,950
New +$230K 0.06% 164

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Round Rock Advisors's GILD Position: Q3 2025 in Review

Round Rock Advisors sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 3,023 shares — an estimated $335K sold.

Round Rock Advisors first reported a position in GILD in Q4 2023 and held it in 7 quarters. The position peaked at $342K in Q1 2025. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

  • Round Rock Advisors reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
  • Round Rock Advisors sold 3,023 Gilead Sciences shares in Q3 2025, an estimated $335K.
  • Round Rock Advisors first reported a position in Gilead Sciences in Q4 2023 and held it in 7 quarters.
  • Round Rock Advisors's Gilead Sciences position peaked at $342K in Q1 2025.
  • 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Round Rock Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.